Listing & Compliance Notices

GeoVax Labs, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 6, 2023, the Company received a notice (the “Notice”) from The Nasdaq Stock Market, LLC ("Nasdaq") stating that Nasdaq has determined to delist the Company's securities from the Nasdaq Capital Market for failure to maintain a minimum bid price of $1.00 per share in accordance with Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Company intends to appeal the Nasdaq determination by requesting a hearing (the "Hearing") before a Nasdaq Hearings Panel (the "Panel") to seek continued listing pending its return to compliance with the Bid Price Requirement. The Hearing requ”

Liberty Resources Acquisition Corp. received a nasdaq compliance regained notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(B), 5450(a)(2), 5800).

“June 5, 2023, indicating that because the Company’s Market Value of Listed Securities was less than $50 million, the Company was no longer in compliance with the Nasdaq Global Market (“ Nasdaq ”) Listing Rule 5450(b)(2)(A), which requires the Company to maintain a Market Value of Listed Securities of at least $50 million (the “ MVLS Requirement ”). The Company was provided 180 calendar days to regain compliance with Listing Rule 5450(b)(2)(A). As previously disclosed on the Form 8-K filed with the SEC on June 20, 2023, the Company received written notice (the “ Public Float Notice ”) from the”

GRAPHJET TECHNOLOGY received a nasdaq deficiency notice notice regarding shareholders.

“received a notice (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) t hat the Company no longer has the minimum required 400 shareholders for continued listing on Nasdaq. Accordingly, the Company’s securities will be delisted unless the Company requests an appeal of this determination as described below . The Company has requested a hearing before the Panel to appeal this Notice as well as the notice received on November 22, 2023, which was previously disclosed on Form 8-K filed on November 28, 2023. Nasdaq has granted the Company’s hearing request, which is”

Blue World Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“December 5, 2023, Blue World Acquisition Corporation (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that, for the previous 30 consecutive business days, the Market Value of Listed Securities (“ MVLS ”) for the Company was below the $50 million minimum MVLS requirement for continued listing on the Nasdaq Global Market (the “ Global Market ”) under Nasdaq Listing Rule 5450(b)(2)(A) (the “ MVLS Rule ”). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect o”

SMART FOR LIFE, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“December 5, 2023, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the Nasdaq stockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market as set forth in Listing Rule 5550(b)(1) (the “Equity Rule”), given that the Company’s Form 10-Q for the period ended September 30, 2023 evidenced stockholders’ equity of $951,836. As previously disclosed, the Company is subject to a mandatory panel monitor until June 7, 2024, which requires the staff of Nasdaq to issue a delist”

Future Health ESG Corp. received a nasdaq delisting notice notice regarding other (rules 5550(a)(3)).

“December 4, 2023, Future Health ESG Corp. (the “Company”), received a written notice (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not regained compliance with Listing Rule 5550(a)(3) (the “Minimum Public Holders Rule”), which requires the Company to have at least 300 public holders for continued listing on Nasdaq, trading of the Company’s common stock will be suspended at the opening of business on December 13, 2023 and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SE”

ELUTIA INC. received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1)).

“f the Exchange Act. ̈ Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 5, 2023, Elutia Inc. (the “Company” or “Elutia”) notified The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Listing Rule 5605(b)(1) (the “Board Independence Rule”), which requires that a majority of the members of the Board of Directors be independent within the meaning of Listing Rule 5605(a)(2). On December 5, 2022, due to a securities offering, the Company lost its status as a “controlled company” exempt from the r”

Quince Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“December 4, 2023, Quince Therapeutics, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the closing bid price of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for the last 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Global Select Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (t”

Adverum Biotechnologies, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“December 6, 2023, Adverum Biotechnologies, Inc. received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying Adverum that for the last 30 consecutive business days the bid price of Adverum’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq listing rule 5450(a)(1). The notification received has no immediate effect on the listing of Adverum’s common stock on Nasdaq. In accordance with listing rule 5810(c)(3)(A), Adverum has 180 calendar days, or until June 3, 2024, to regai”

Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“ecutive business days preceding the date of the Notices, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Company was provided 180 calendar days, or until December 5, 2023, to regain compliance with one of the Financial and Liquidity Standards and the Minimum Bid Price Requirement.”

Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)).

“i) for 30 consecutive business days preceding the date of the Notices, the market value of the Company’s common stock was less than $35.0 million, which does not meet the requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “Market Value Rule”) and the Company did not meet any of the alternative continued listing requirements set forth in Nasdaq Listing Rule 5550(b) (the “Financial and Liquidity Standards”), and (ii) for 30 consecutive business days preceding the date of the Notices, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).”

SELLAS Life Sciences Group, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“December 6, 2023, SELLAS Life Sciences Group, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it no longer meets Nasdaq’s requirements for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”) because, for a period of 30 consecutive business days, the market value of the Company’s common stock, calculated based upon the most recent total shares outstanding multiplied by the closing bid price per share, has not maintained a minimum of $35.0 million. The letter does not impact the Company’s”

AGENUS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 4, 2023, Agenus Inc. (the “Company") was notified by the Nasdaq Stock Market's Listing Qualifications Department that the Company’s common stock's closing bid price had not met the $1.00 minimum bid price requirement for 31 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2). This situation, however, will not impact the listing of the Company's common stock on the Nasdaq Capital Market for a minimum of 180 days with the possibility of an extension of another 180 days. The Company has been granted an initial automatic 180-day period, ending on June 3, 2024, to rect”

EDUCATIONAL DEVELOPMENT CORP received a nasdaq deficiency notice notice regarding board independence (rules 5605).

“December 5, 2023, Educational Development Corporation (the “ Company ”) received a deficiency letter (the “1 st Deficiency Letter ”) from NASDAQ Regulation (the “ NASDAQ ”) indicating that the Company is not in compliance with the NASDAQ continued Listing Rules (“Rules”) set forth in Section 5450(A)(i) because its shares of common stock, par value $0.20 per share (the “ Common Stock ”), have been selling below $1.00 per share during the period between October 23,2023 and December 3, 2023. However, as also indicated in the 1 st Deficiency Letter, the Rules provide the Company a compliance perio”

EDUCATIONAL DEVELOPMENT CORP received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(A)(i)).

“December 5, 2023, Educational Development Corporation (the “ Company ”) received a deficiency letter (the “1 st Deficiency Letter ”) from NASDAQ Regulation (the “ NASDAQ ”) indicating that the Company is not in compliance with the NASDAQ continued Listing Rules (“Rules”) set forth in Section 5450(A)(i) because its shares of common stock, par value $0.20 per share (the “ Common Stock ”), have been selling below $1.00 per share during the period between October 23,2023 and December 3, 2023. However, as also indicated in the 1 st Deficiency Letter, the Rules provide the Company a compliance perio”

Vestand Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(4)).

“December 1, 2023, Yoshiharu Global Co., a Delaware corporation (the “Company”), received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer meets the minimum 500,000 publicly held shares requirement for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(a)(4). The notification received has no immediate effect on the listing of the Company’s common stock on Nasdaq. Under Nasdaq Listing Rules, the Company has until January 16, 2024 to provide Nasdaq with a”

Jet.AI Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)(A)).

“December 1, 2023, Jet.AI Inc., a Delaware corporation (the “Company”) received a notification letter (the “Letter”) from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its amount of stockholders’ equity has fallen below the $10,000,000 required minimum for continued listing on The Nasdaq Global Market set forth in Nasdaq Listing Rule 5550(b)(1)(A). The Company’s stockholders’ equity as of September 30, 2023 was $(4,257,094), as reported in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023. The Lette”

Goldenstone Acquisition Ltd. received a nasdaq deficiency notice notice regarding shareholders (rules 5550(a)(3)).

“December 4, 2023, Goldenstone Acquisition Limited (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company was not in compliance with the requirement that it maintain at least 300 public holders pursuant to Listing Rule 5550(a)(3). The Staff has provided the Company with 45 calendar days from the date of the Notice, or until January 18, 2024, to submit a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to180 calendar days from”

Spectaire Holdings Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“December 5, 2023, Spectaire Holdings Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days prior to the date of the Letter, the Company’s Market Value of Listed Securities (“MVLS”) was below the $50 million minimum MVLS requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on”

Sports Entertainment Gaming Global Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(C)).

“November 29, 2023, Lottery.com, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that based upon its review of the Company’s Market Value of Publicly Held Shares (“MVPHS”) for the last 30 consecutive business days, the Company no longer meets the minimum requirement of $5,000,000 set forth in Nasdaq Listing Rule 5450(b)(1)(C). However, under the Listing Rules, the Company was provided a 180-calendar day grace period to regain compliance, through May 28, 2024. If at anytime during the complianc”

RiskOn International, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“the Securities and Exchange Commission (the “ SEC ”), which will remove the Company’s common stock from listing and registration on Nasdaq. The Company will request an appeal of the Staff’s determination to a Hearings Panel (the “ Panel ”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, which is required to be submitted electronically no later than December 8, 2023. The hearing request will stay the suspension of the Company’s common stock and the filing of the Form 25-NSE pending the Panel’s decision, and the Company’s common stock will continue to trade on the N”

Mobiquity Technologies, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“December 5, 2023, the Company received a letter from the Panel notifying the Company, among other things, (a) that despite the Company’s claims of having regained compliance with a stockholder equity value of over $2.5 million, and its claims that it will see increased revenue in the new year, Nasdaq concluded that in light of the Company’s burn rate, the Company’s stockholder equity was below the minimum, and (b) that the Panel has determined to delist the Company’s securities from trading on Nasdaq, based on the Company’s historical financial information on expenses and burn rate, and the Pa”

Troika Media Group, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“December 7, 2023, Troika Media Group, Inc. (the “Company”) received a determination letter (“Determination Letter”) from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that Nasdaq has determined that, in accordance with its authority under Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1, the Company’s securities will be suspended from trading at the opening of business on December 18, 2023 and delisted from Nasdaq. Nasdaq based its determination upon concerns related to (i) the Company’s announcement that the Company had filed for protection under Chapter 11 of the United States Ba”

BNB PLUS CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 1, 2023, Applied DNA Sciences, Inc. (the “Company”) received written notice (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement e”

Newton Golf Company, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 5, 2023, Sacks Parente Golf, Inc. (the “Company”) received a written notice (the “Notice”) from the NASDAQ Stock Market LLC (“Nasdaq”) that the Company has not been in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for a period of 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum closing bid price requirement exists if the deficiency continues for a period of 30”

KORE Group Holdings, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“December 6, 2023, KORE Group Holdings, Inc. (the “Company” or “KORE”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company’s warrants to purchase common stock (the “Warrants”) are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual, and that the NYSE Regulation has determined to commence proceedings to delist the Warrants. Each Warrant is presently exercisable for one share of the Company’s common stock at an exercise price per share of $11.50, ticker symbol “KORE.WS”. To e”

Edoc Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1), 5810(b)).

“November 30, 2023, Edoc Acquisition Corp., a special purpose acquisition company incorporated as a Cayman Islands exempted company (the “Company”) received a notice (the “Notice”) from the staff (the “Staff”) of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”), in violation of the Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), serves as an additional basis for delisting the Company’s”

RYTHM, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“October 17, 2023, the Company received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of Nasdaq notifying the Company that it was not in compliance with Nasdaq’s continued listing requirements as a result of its failure to file the Delinquent Reports in a timely manner. In connection with receipt of the Staff Determination, the Company timely requested a hearing with the Nasdaq Hearings Panel (the “Panel”) The Notice noted that the Panel will consider the Company’s non-compliance with the Listing Rule in making its determination regarding”

RYTHM, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“December 1, 2023, the Company received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company reported stockholders’ equity of $(17.17) million in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, the Company is no longer in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Listing Rule”), which requires that listed companies maintain a minimum of $2.5 million in stockholders’ equity. The notice has no immediate effect and will not immediately result in the suspension of trading or delisting of the Company’s shares of commo”

Presidio Property Trust, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“listing of the Company’s common stock, which will continue to be listed and traded on the Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of the Nasdaq Capital Market. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other listing criteria of the Nasdaq Capital Market.”

Iris Acquisition Corp received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“November 27, 2023, from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because it has not yet filed its Form 10-Q for the period ended September 30, 2023 (the “Filing”), it no longer complies with Listing Rule 5250(c)(1) (the “Rule”) of Nasdaq’s Listing Rules (the “Rules”) for continued listing. In accordance with the Rule, the Company has 60 calendar days to submit a plan to regain compliance and if Nasdaq accepts the Company’s plan, Nasdaq can grant an exception of up to 180 calendar days from the Filing’s due date, or”

TuHURA Biosciences, Inc./NV received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).

“November 6, 2023, the Company submitted to the Staff a plan to regain compliance with the Stockholders’ Equity Requirement. On December 4, 2023, the Staff provided notice (the “Notice”) to the Company that it granted an extension of up to 180 days from September 20, 2023, or through March 18, 2024, to regain compliance with the Stockholders’ Equity Requirement, conditioned upon the Company’s achievement of certain milestones included in the plan of compliance previously submitted to the Staff. If the Company fails to evidence compliance upon filing its periodic report for the quarter ending Ma”

Neptune Wellness Solutions Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 30, 2023, Neptune Wellness Solutions Inc. (the “Company”) received a letter from the staff of the Listing Qualifications Department of The NASDAQ Stock Market LLC (“NASDAQ Staff”) indicating that unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (“Panel”) by December 7, 2023, the Company's common stock would be subject to delisting based upon its non-compliance with NASDAQ's Minimum Bid Requirement (as defined below) and NASDAQ’s Stockholders’ Equity Requirement (as defined below), as set forth in NASDAQ Listing Rules 5550(a)(2) and 5550 (b)(1), resp”

Neptune Wellness Solutions Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 30, 2023, Neptune Wellness Solutions Inc. (the “Company”) received a letter from the staff of the Listing Qualifications Department of The NASDAQ Stock Market LLC (“NASDAQ Staff”) indicating that unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (“Panel”) by December 7, 2023, the Company's common stock would be subject to delisting based upon its non-compliance with NASDAQ's Minimum Bid Requirement (as defined below) and NASDAQ’s Stockholders’ Equity Requirement (as defined below), as set forth in NASDAQ Listing Rules 5550(a)(2) and 5550 (b)(1), resp”

Trinity Place Holdings Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

“November 29, 2023, the Company received a deficiency letter (the “ Deficiency Letter ”) from the NYSE American LLC (the “ NYSE American ”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide (the “Guide”). Section 1003(a)(i) of the Guide requires a listed company’s stockholders’ equity be at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. Section 1003(a)(ii) of the Guide requires a li”

ShoulderUP Technology Acquisition Corp. received a nyse deficiency notice notice regarding market value (rules 802.01B).

“December 1, 2023, ShoulderUp Technology Acquisition Corp., a Delaware corporation (the “ Company ”) received notice (the “ Notice ”) from the New York Stock Exchange (the “ NYSE ”) that the Company, as of November 28, 2023, is not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE’s Listed Company Manual (the “ Listing Rule ”). The Listing Rule requires a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly held shares (a “ public float ”) over a consecutive 30 trading day period of at leas”

International Media Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“November 29, 2023, International Media Acquisition Corp. (the “Company”) received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 with the Securities and Exchange Commission (“SEC”). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC. Under Nasdaq rules, the Company has 60 calendar days from the”

Evelo Biosciences, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5605(b)(1), 5605(c)(2), 5605(d)(2), 5605(e)(1)).

“nd (iii) the separation of the Company’s Chief Executive Officer and Chief Financial Officer from the Company, it is the Staff’s belief that the Company no longer has an operating business and is a “public shell” as that term is defined in Nasdaq Listing Rule 5101. Terms used but defined herein are as defined under the rules of Nasdaq. The Staff also indicated that that the Company is not compliant with the following requirements for continued listing on Nasdaq: (1) $50,000,000 minimum Market Value of Listed Securities, (2) $15,000,000 minimum Market Value of Publicly Held Shares and (3) a minimum bid price of $1 per share.”

Kezar Life Sciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“December 1, 2023, Kezar Life Sciences, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The notification received has no immediate effect on the listing of the Company’s common stock on the Nasdaq Stock Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the C”

Altisource Asset Management Corp received a nyse_american delisting notice notice regarding stockholders equity (rules 1009(a), 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“November 30, 2023, Altisource Asset Management Corporation (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (“NYSE” or the “Exchange”) that the NYSE would delist the Company’s shares of common stock (the “Securities”) from the Exchange. NYSE Regulation staff has determined that the Company is no longer qualified for listing pursuant to Section 1009(a) of the NYSE American Company Guide, citing non-compliance with Sections 1003(a)(i), (ii) and (iii) thereof. The Company has a right to appeal this determination, provided that it files a written request fo”

FiEE, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(a)(5), 5810(c)(3)(D)).

“November 30, 2023, Minim, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company, that because the Market Value of Publicly Held Shares (the number of shares outstanding multiplied by the current market price of the firm’s shares) for the Company’s common stock listed on Nasdaq was below $1,000,000 for 30 consecutive business days, the Company no longer meets the minimum value requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(a)(5), which requires a minimum Market Value of $1,000,000. The notification from Nasdaq has no”

NGM BIOPHARMACEUTICALS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“December 1, 2023, NGM Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), received a letter from the Listing Qualifications Staff (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The notification received has no immediate effect on the listing of the Company’s common stock on The Nasdaq Global Select Market. In”

NextPlay Technologies Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“7, 3023 and will be delisted from the Nasdaq Capital Market. The Company intends to submit an appeal of the Staff’s determination to a Hearings Panel, as well as a request to stay the suspension of its common stock pending the hearing date, pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, no later than the December 5, 2023 deadline. If the appeal and request for hearing is timely submitted, the suspension of the Company’s common stock will automatically be stayed fifteen days from the date of the appeal request. Nasdaq will notify the Company of its decision as to w”

CorEnergy Infrastructure Trust, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“December 1, 2023, CorEnergy Infrastructure Trust, Inc. (the “Company”) received a written notice from the staff of NYSE Regulation notifying the Company that NYSE Regulation had determined to commence proceedings to delist the Company's common stock (trading symbol: CORR) and preferred stock (trading symbol: CORRPrA) from the New York Stock Exchange (“NYSE”). Trading in the Company’s common stock and preferred stock on the NYSE was suspended after the market close on December 1, 2023. NYSE Regulation reached its decision to delist the common stock and preferred stock pursuant to Section 802.01”

SONIC FOUNDRY INC received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)).

“On February 14, 2023, the Staff notified the Company that it failed to comply with Nasdaq’s $2,500,000 minimum stockholders’ equity requirement for continued listing or any of the alternative requirements in Listing Rule 5550(b). In that regard, the Company submitted its plan to regain compliance and was granted an extension until July 14, 2023.”

SONIC FOUNDRY INC received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“As previously disclosed, on January 6, 2023, the Nasdaq Listing Qualifications staff (the “Staff”) notified the Company that it no longer complied with the minimum bid price requirement under Listing Rule 5550(a)(2). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until July 6, 2023, to regain compliance with Listing Rule 5550(a)(2).”

ENGLOBAL CORP received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 27, 2023, ENGlobal Corporation (the “Company”) received written notice from The Nasdaq Stock Market Inc. (“Nasdaq”) notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1) for continued listing due to its failure to maintain a minimum of $2.5 million in stockholders' equity. In the Company's Form 10-Q for the period ended September 30, 2023, the Company reported stockholders' equity of approximately $2.1 million. Nasdaq also determined that the Company does not meet the alternatives of market value of listed securities or net income from continuing”

DAILY JOURNAL CORP received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

“November 29, 2023, Daily Journal Corporation (the “Company”) notified The Nasdaq Stock Market (“Nasdaq”) of the passing of Charles T. Munger on November 28, 2023. Mr. Munger was a director of the Company and a member of its audit committee. The Company notified Nasdaq that, as a result of Mr. Munger’s passing, the Company’s audit committee currently has two members, contrary to Nasdaq Listing Rule 5605(c)(2)(A)’s requirement that the Company have an audit committee of at least three members. Accordingly, the Company notified Nasdaq that the Company has fallen out of compliance with Nasdaq List”

Red Cat Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“tisfy a Continued Listing Rule or Standard; Transfer of Listing On November 28, 2023, Red Cat Holdings, Inc. (the “Company”) received a letter from The Nasdaq Stock Market, LLC (“Nasdaq”), indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s common stock was less than $1.00 for the previous 30 consecutive business days. The letter has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market. Under Nasdaq”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 27, 2023, Inspire Veterinary Partners, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s common stock is subject to potential delisting from the Nasdaq because for a period of 30 consecutive business days, the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Marketplace Rule 5550(a)(2) (the “Bid Price Rule”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s”